SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-062935
Filing Date
2013-11-19
Accepted
2013-11-19 11:16:55
Documents
2
Period of Report
2013-11-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v361020_8k.htm 8-K 18619
2 EXHIBIT 99.1 v361020_ex99-1.htm EX-99.1 11394
  Complete submission text file 0001144204-13-062935.txt   31319
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 131228988
SIC: 2834 Pharmaceutical Preparations